Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Issued
Ratios

Cartesian Therapeutics (RNAC) Long-Term Debt Repayments: 2015-2023

Historic Long-Term Debt Repayments for Cartesian Therapeutics (RNAC) over the last 2 years, with Sep 2023 value amounting to $24.9 million.

  • Cartesian Therapeutics' Long-Term Debt Repayments was N/A to $24.9 million in Q3 2023 from the same period last year, while for Sep 2023 it was $44.2 million, marking a year-over-year change of. This contributed to the annual value of $27.5 million for FY2023, which is N/A change from last year.
  • Latest data reveals that Cartesian Therapeutics reported Long-Term Debt Repayments of $24.9 million as of Q3 2023, which was up 64.57% from $15.1 million recorded in Q3 2020.
  • In the past 5 years, Cartesian Therapeutics' Long-Term Debt Repayments ranged from a high of $24.9 million in Q3 2023 and a low of $700,000 during Q3 2019.
  • Over the past 1 years, Cartesian Therapeutics' median Long-Term Debt Repayments value was $24.9 million (recorded in 2023), while the average stood at $24.9 million.
  • Data for Cartesian Therapeutics' Long-Term Debt Repayments shows a peak YoY soared of 2,059.00% (in 2020) over the last 5 years.
  • Cartesian Therapeutics' Long-Term Debt Repayments (Quarterly) stood at $2.1 million in 2019, then soared by 2,059.00% to $15.1 million in 2020, then reached $24.9 million in 2023.
  • Its Long-Term Debt Repayments was $24.9 million in Q3 2023, compared to $15.1 million in Q3 2020 and $2.1 million in Q2 2020.